investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes
Xifeng Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Xifeng Wu
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Matthew L. Meyerson
How do genome alterations cause human lung cancer?
Trachea, bronchus and lung
Shioko Kimura
Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung
Trachea, bronchus and lung
Pathology
Dolph Hatfield
Role of Selenium in Development and Health
Trachea, bronchus and lung
Eric Haura
Specialized Program of Research Excellence (SPORE) in Lung Cancer
Trachea, bronchus and lung
Pathology
Ruth E Malone
Investigating Institutional Influences on Tobacco Control
Trachea, bronchus and lung
Eusebio Manchado-Robles
Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers
Trachea, bronchus and lung
Eric Alejandro Sweet-Cordero
Novel effectors of Kras in oncogenesis, senescence and tumor progression
Trachea, bronchus and lung
Nathanael Schiander Gray
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
Trachea, bronchus and lung
Bingliang Fang
Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing
Trachea, bronchus and lung